JP2009538276A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538276A5
JP2009538276A5 JP2009507606A JP2009507606A JP2009538276A5 JP 2009538276 A5 JP2009538276 A5 JP 2009538276A5 JP 2009507606 A JP2009507606 A JP 2009507606A JP 2009507606 A JP2009507606 A JP 2009507606A JP 2009538276 A5 JP2009538276 A5 JP 2009538276A5
Authority
JP
Japan
Prior art keywords
deoxynojirimycin
pentane
neopentyloxy
methoxy
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2009507606A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538276A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NL2007/050177 external-priority patent/WO2007123403A1/en
Publication of JP2009538276A publication Critical patent/JP2009538276A/ja
Publication of JP2009538276A5 publication Critical patent/JP2009538276A5/ja
Ceased legal-status Critical Current

Links

JP2009507606A 2006-04-24 2007-04-24 嚢胞性線維症の改良型治療 Ceased JP2009538276A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79408806P 2006-04-24 2006-04-24
PCT/NL2007/050177 WO2007123403A1 (en) 2006-04-24 2007-04-24 Improved treatment of cystic fibrosis

Publications (2)

Publication Number Publication Date
JP2009538276A JP2009538276A (ja) 2009-11-05
JP2009538276A5 true JP2009538276A5 (enExample) 2010-04-08

Family

ID=38283020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009507606A Ceased JP2009538276A (ja) 2006-04-24 2007-04-24 嚢胞性線維症の改良型治療

Country Status (10)

Country Link
US (1) US8410081B2 (enExample)
EP (1) EP2010551B1 (enExample)
JP (1) JP2009538276A (enExample)
CN (1) CN101479288B (enExample)
AT (1) ATE479696T1 (enExample)
AU (1) AU2007241622A1 (enExample)
BR (1) BRPI0710883A2 (enExample)
CA (1) CA2650311A1 (enExample)
DE (1) DE602007008870D1 (enExample)
WO (1) WO2007123403A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0712494D0 (en) * 2007-06-27 2007-08-08 Isis Innovation Substrate reduction therapy
ES2579628T3 (es) 2009-02-23 2016-08-12 Emergent Virology Llc Iminoazúcares y métodos de tratamiento de enfermedades virales
EP2400843B1 (en) * 2009-02-24 2015-11-11 United Therapeutics Corporation Iminosugars and methods of treating arenaviral infections
WO2010144759A1 (en) 2009-06-12 2010-12-16 United Therapeutics Corporation Iminosugars and methods of treating bunyaviral and togaviral diseases
JP5575246B2 (ja) * 2009-09-04 2014-08-20 ユナイテッド セラピューティクス コーポレイション ポックスウイルス感染の治療方法
EP2473482B1 (en) * 2009-09-04 2014-03-05 United Therapeutics Corporation Methods of treating orthomyxoviral infections
CN102595895A (zh) * 2009-09-04 2012-07-18 联合治疗公司 亚氨基糖以及治疗丝状病毒性疾病的方法
GB201000499D0 (en) 2010-01-13 2010-03-03 Fleet George W J Treatment of cystic fibrosis
WO2011095772A2 (en) 2010-02-04 2011-08-11 Summit Corporation Plc Novel iminosugar therapeutics
GB201006434D0 (en) 2010-04-19 2010-06-02 Summit Corp Plc Novel iminosugar combinations
US10350277B2 (en) 2011-09-07 2019-07-16 Icahn School Of Medicine At Mount Sinai Ceramidase and cell differentiation
ES2786128T3 (es) * 2012-06-01 2020-10-08 Icahn School Med Mount Sinai Niveles de ceramida en el tratamiento y prevención de infecciones
WO2014086934A1 (en) * 2012-12-05 2014-06-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) Diagnosis of cystic fibrosis
JP6832158B2 (ja) 2013-03-14 2021-02-24 アイカーン スクール オブ メディシン アット マウント サイナイ 治療用酸性セラミダーゼ組成物ならびにそれを作製および使用する方法
US20190142782A1 (en) 2016-04-11 2019-05-16 Spedding Research Solutions Inhibitors of glucosylceramide degradation in the treatment of diseases of the motor units
HRP20251697T1 (hr) 2017-06-01 2026-02-27 Idorsia Pharmaceuticals Ltd Kristalni oblik n-butildeoksigalaktonojirimicina
MX2023010658A (es) * 2021-03-12 2023-10-30 Excepgen Inc Sistemas y metodos para la expresion de proteinas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177447B1 (en) * 1996-07-15 2001-01-23 Universiteit Van Amsterdam Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors
AU5799500A (en) 1999-06-29 2001-01-22 Mcgill University Human alpha 1,2-mannosidase
EP1528056A1 (en) * 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
FR2861991B1 (fr) * 2003-11-07 2008-01-18 Centre Nat Rech Scient Utilisation d'inhibiteurs de glucosidase pour une therapie de la mucoviscidose
WO2005123055A2 (en) 2004-06-14 2005-12-29 Musc Foundation For Research Development Methods for treating inflammatory disorders
CN101267779A (zh) * 2005-07-27 2008-09-17 福罗里达大学研究基金会有限公司 使用热休克治疗眼睛疾病

Similar Documents

Publication Publication Date Title
JP2004519469A5 (enExample)
JP2004538303A5 (enExample)
JP2011513196A5 (enExample)
JP2010504343A5 (enExample)
JP2007016035A5 (enExample)
JP2006526590A5 (enExample)
JP2009535370A5 (enExample)
JP2007514005A5 (enExample)
JP2007501251A5 (enExample)
JP2007529532A5 (enExample)
JP2012502885A5 (enExample)
JP2010526840A5 (enExample)
JP2009500423A5 (enExample)
WO2009064374A8 (en) Oral formulations of bis(thiohydrazide amides)
ES2489265T3 (es) Asociación de inhibidores de la HMG-CoA reductasa atorvastatina o simvastatina con un inhibidor de la fosfodiesterasa 4, tal como roflumilast para el tratamiento de enfermedades pulmonares inflamatorias
WO2011106688A1 (en) Bis-fatty acid conjugates and their uses
JP2000159790A5 (enExample)
JP2005508963A5 (enExample)
RU2009119567A (ru) Уменьшение избыточной массы тела или ожирения
SE0401655D0 (sv) New compounds
JP2011068692A5 (enExample)
JP2022529814A5 (enExample)
EA200500240A1 (ru) Новый способ синтеза соединений 1,3,4,5-тетрагидро-2h-3-бензазепин-2-она и применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
JP2010533717A5 (enExample)
JP2005511708A5 (enExample)